D
Über
Butrint Aliu joined Pureos Bioventures in 2023 and previously led an antiviral drug development project at the University of Basel. He collaborated with Polyneuron Pharmaceuticals AG on novel therapies targeting rare neurological disorders during his PhD.
Schwerpunkte
["Antiviral drug development", "Neurological disorders", "Pharmaceutical Sciences", "Bioventures"]
Region
📍 Ansässig in Basel
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...